Elvitegravir

Overview

Elvitegravir (GS-9137; JTK-303; D06677) is an HIV integrase inhibitor for HIV-1 IIIB , HIV-2 EHO and HIV-2 ROD with IC 50 of 0.7 nM, 2.8 nM and 1.4 nM, respectively.

Application

Products | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Viral Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Coronavirus Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > HIV Integrase | Products > Signaling Pathways > HIV

Product Information

• Catalog No.: HY-14740
• CAS No.: 697761-98-1
• Molecular Formula: C23H23ClFNO5
• Molecular Weight: 447.88
• Purity: 99.90%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 1 year , -20°C, 6 months
• Solubility: 2.5 mg/mL (5.58 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source